Literature DB >> 2505369

Etiology of nasal polyps associated with aspirin-sensitive asthma.

T Yamashita1, H Tsuji, N Maeda, K Tomoda, T Kumazawa.   

Abstract

It is well known that nasal polyps occur at high frequency in aspirin-sensitive asthma (ASA). Their etiology, however, remains obscure. Therefore, histopathologic observations and measurements of arachidonic acid metabolites were carried out to investigate the etiopathogenesis of nasal polyps in ASA. Abundant eosinophils and degranulated mast cells were found in the tissue of nasal polyp-associated ASA cases. Electron-microscopic analyses of these eosinophils revealed that high-electron-dense material had disappeared from the cytoplasmic granules' central crystalloids. Arachidonic acid metabolites (PGE2, PGF2, 6-keto-PGF1 and TXB2) from the cyclooxygenase pathway were measured via gas mass-chromatography. Leukotrienes (LTC4 and LTD4) from the lipoxygenase pathway were measured via HPLC-radioimmunoassay. Especially noteworthy are the high level of leukotrienes and low level of prostaglandins in nasal polyp-associated ASA. The etiopathogenesis of nasal polyps in aspirin-sensitive asthma is postulated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505369

Source DB:  PubMed          Journal:  Rhinol Suppl        ISSN: 1013-0047


  9 in total

1.  Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.

Authors:  S Nasser; P E Christie; R Pfister; A R Sousa; A Walls; M Schmitz-Schumann; T H Lee
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

Review 2.  Pathogenesis of aspirin-exacerbated respiratory disease.

Authors:  Donald D Stevenson; Bruce L Zuraw
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

Review 3.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs (NSAIDs).

Authors:  Ronald A Simon; Jennifer Namazy
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

Review 5.  Pathogenesis of aspirin-exacerbated respiratory disease and reactions.

Authors:  Tanya M Laidlaw; Joshua A Boyce
Journal:  Immunol Allergy Clin North Am       Date:  2012-12-23       Impact factor: 3.479

Review 6.  Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.

Authors:  Ronald A Simon
Journal:  Curr Allergy Asthma Rep       Date:  2004-01       Impact factor: 4.919

Review 7.  Cyclooxygenases and the pathogenesis of chronic rhinosinusitis and nasal polyposis.

Authors:  Josep M Guilemany; Jordi Roca-Ferrer; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

Review 8.  Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.

Authors:  Hanki Park; Youngwoo Choi; Chang-Gyu Jung; Hae-Sim Park
Journal:  Mediators Inflamm       Date:  2017-08-09       Impact factor: 4.711

Review 9.  Samter's Triad: State of the Art.

Authors:  Sung-Dong Kim; Kyu-Sup Cho
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-04-13       Impact factor: 3.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.